Recombinant human erythropoietin (rhEPO) is a form of therapy that is often resorted to because of its ability to reverse renal anemia, even though, in order to maintain desired laboratory parameters associated with anemia, dosing is individual and varies in each patient [59,60,61]. Here, EPO is linked to anemia.